参考文献/References:
[1] 国家心血管病医疗质量控制中心专家委员会心力衰竭专家工作组. 2020中国心力衰竭医疗质量控制报告[J]. 中国循环杂志,2021,36(3):221-238.
[2] 蒋昭隆,刘剑雄. 心肺运动试验在冠心病的运用现状[J]. 心血管病学 进展,2019,40(9):1290-1293.
[3] Agostoni P,Sciomer S,Palermo P,et al. Minute ventilation/carbon dioxide production in chronic heart failure[J]. Eur Respir Rev,2021,30(159):200141.
[4] Agostoni P,Dumitrescu D. How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure[J]. Int J Cardiol,2019,288:107-113.
[5] Grinstein J,Sawalha Y,Medvedofsky DA,et al. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device:a fresh look at cardiopulmonary stress testing for prognostication [J]. J Artif Organs,2021,24(4):425-432.
[6] Wagner J,Agostoni P,Arena R,et al. The role of gas exchange variables in cardiopulmonary exercise testing for risk stratification and management of heart failure with reduced ejection fraction[J]. Am Heart J,2018,202:116-126.
[7] Dorken Gallastegi A,Ergi GD,Kahraman ?,et al. Prognostic value of cardiopulmonary exercise test parameters in ventricular assist device therapy[J]. ASAIO J,2021 Sep 7. DOI:10.1097/MAT.0000000000001571. Online ahead of print.
[8] Salvioni E,Corrà U,Piepoli M,et al. Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction[J]. ESC Heart Fail,2020,7(1):371-380.
[9] Sinagra G,Carriere C,Clemenza F,et al. Risk stratification in cardiomyopathy[J]. Eur J Prev Cardiol,2020,27(2S):52-58.
[10] Magrì D,Santolamazza C. Cardiopulmonary exercise test in hypertrophic cardiomyopathy[J]. Ann Am Thorac Soc,2017,14(S1):S102-S109.
[11] Yunis A,Doros G,Luptak I,et al. Use of ventilatory efficiency slope as a marker for increased mortality in wild-type transthyretin cardiac amyloidosis[J]. Am J Cardiol,2019,124(1):122-130.
[12] Guazzi M,Arena R,Halle M,et al. 2016 focused update:clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J]. Circulation,2016,133(24):e694-e711.
[13] Ilarraza-Lomelí H,Chávez IM,Casta?eda-López J,et al. Comparison of peak oxygen uptake and VE/VCO2 slope,between children with and without heart failure [J]. Gac Med Mex,2016,152(6):734-740.
[14] Moore B,Brubaker PH,Stewart KP,et al. VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls [J]. J Card Fail,2007,13(4):259-262.
[15] Magr? D,Piepoli M,Corr? U,et al. Cardiovascular death risk in recovered mid-range ejection fraction heart failure:insights from cardiopulmonary exercise test[J]. J Card Fail,2020,26(11):932-943.
[16] Paolillo S,Veglia F,Salvioni E,et al. Heart failure prognosis over time:how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years[J]. Eur J Heart Fail,2019,21(2):208-217.
[17] Valentim Goncalves A,Pereira-da-Silva T,Soares R,et al. Prognostic value of VE/VCO2 slope in overweight heart failure patients [J]. Am J Cardiovasc Dis,2020,10(5):578-584.
[18] Kato Y,Suzuki S,Uejima T,et al. Relationship between the prognostic value of ventilatory efficiency and age in patients with heart failure[J]. Eur J Prev Cardiol,2018,25(7):731-739.
[19] Carriere C,Corrà U,Piepoli M,et al. Anaerobic threshold and respiratory compensation point identification during cardiopulmonary exercise tests in chronic heart failure[J]. Chest,2019,156(2):338-347.
[20] Guazzi M,Borlaug B,Metra M,et al. Revisiting and implementing the Weber and ventilatory functional classifications in heart failure by cardiopulmonary imaging phenotyping[J]. J Am Heart Assoc,2021,10(5):e018822.
[21] Constantini K,Bouillet AC,Wiggins CC,et al. Ventilatory responsiveness during exercise and performance impairment in acute hypoxia[J]. Med Sci Sports Exerc,2021,53(2):295-305.
[22] Chourdakis E,Koniari I,Velissaris D,et al. Beta-blocker treatment in heart failure patients with atrial fibrillation:challenges and perspectives[J]. J Geriatr Cardiol,2021,18(5):362-375.
[23] Abdelbasset WK,Osailan A. Sleep quality and ventilatory effciency in elderly heart failure patients:a pilot study on the short-term e?ect of 4-week low-intensity aerobic exercise [J]. Kardiologiia,2020,60(6):102-106.
[24] Amorim S,Campelo M,Martins E,et al. Prevalence,predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy[J]. Rev Port Cardiol,2016,35(5):253-260.
[25] Vitale G,Romano G,Di Franco A,et al. Early effects of sacubitril/valsartan on exercise tolerance in patients with heart failure with reduced ejection fraction[J]. J Clin Med,2019,8(2):262.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(5):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(5):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(5):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(5):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(5):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]蒋昭隆,刘剑雄.心肺运动试验在心脏瓣膜病的运用现状[J].心血管病学进展,2019,(6):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
JIANG Zhaolong,LIU Jianxiong.Application of Cardiopulmonary Exercise Test in Cardiac Valvular Disease[J].Advances in Cardiovascular Diseases,2019,(5):951.[doi:10.16806/j.cnki.issn.1004-3934.201.06.028]
[9]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[10]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]